Wondrous Stock: Dolby Laboratories, Inc. (NYSE: DLB)

On 23 Jan 2020, Dolby Laboratories, Inc. (NYSE: DLB) spotted trading -0.88% off 52-week high price. On the other end, the stock has been noted 24.00% away from the low price over the last 52-weeks. The stock changed 0.39% to recent value of $69.55. The stock transacted 305283 shares during most recent day however it has an average volume of 322.82K shares. The company has 99.77M of outstanding shares and 62.64M shares were floated in the market.

Dolby Laboratories, Inc. (DLB) recently reported the Company’s financial results for the fourth quarter and fiscal year that ended September 27, 2019. For the fourth quarter, Dolby stated total revenue of $298.8M, contrast to $240.6M for the fourth quarter of fiscal 2018. For fiscal 2019, Dolby stated total revenue of $1.24B, contrast to $1.05B for fiscal 2018.

Fiscal 2019 GAAP net income was $255.2M, or $2.44 per diluted share, contrast to $41.7M, or $0.39 per diluted share for fiscal 2018. On a non-GAAP basis, fiscal 2019 net income was $334.6M, or $3.20 per diluted share, contrast to $215.8M, or $2.02 per diluted share, for fiscal 2018. Fiscal 2019 cash flows from operations was $327.7M, contrast to $352.2M for fiscal 2018.

As before indicated, Dolby adopted Accounting Standards Codification Topic 606, Revenue from Contracts with Consumers (ASC 606) in the first quarter of fiscal 2019, and recently’s reported results and the financial outlook are presented in accordance with that new revenue standard. Dolby adopted ASC 606 using the full retrospective transition method, therefore all previous periods are also presented in accordance with the new revenue standard. Included at the end of this press release are financial results for fiscal 2017, fiscal 2018, and the four quarters of fiscal 2018, as adjusted in accordance with ASC 606.


Recently, Dolby reported a cash dividend of $0.22 per share of Class A and Class B ordinary stock, payable on December 4, 2019, to stockholders of record as of the close of business on November 26, 2019.

Its earnings per share (EPS) expected to touch remained 124.00% for this year while earning per share for the next 5-years is expected to reach at 16.00%. DLB has a gross margin of 87.00% and an operating margin of 20.70% while its profit margin remained 20.50% for the last 12 months.   According to the most recent quarter its current ratio was 4.5 that represents company’s ability to meet its current financial obligations. The price moved ahead of 0.95% from the mean of 20 days, 1.86% from mean of 50 days SMA and performed 7.62% from mean of 200 days price. Company’s performance for the week was 0.68%, 2.61% for month and YTD performance remained 1.09%.


Mary Smith

Mary Smith– Health Industry My Name is Mary Smith, and I am 29 years old who is an industrialist other than a writer. I want to catch the attention of my audience and publishers without sounds too dry and dull. I am that sort of person who adores his spare time by writing my thoughts and ideas for my audience or readers. My writing skills are not confined to any specific field, I wrote on many topics, but healthcare sector and Stock Market articles are always my favorite. I love to express myself by creative modes such as drawing, singing, and writing. I love to spend my leisure time with my beloved cat, sleep or by playing my favorite video games.

Leave a Reply

Your email address will not be published. Required fields are marked *